HIV Malignancy Specimens for Research at No Charge
It’s National Cancer Prevention and Early Detection Month!(https://www.whitehouse.gov/briefing-room/presidential-actions/2024/03/29/a-proclamation-on-cancer-control-month-2024/). Human papillomavirus (HPV) is the most the common sexually transmitted infection (STI) in the United States (per CDC’s STD Facts on HPV), and is …
Join the world’s EBV and KSHV experts at the upcoming 3rd Joint International Symposium on EBV & KSHV & Related Agents & Diseases: June 29-July 3, 2024 Boston, USA. The …
Drs. Elaine Jaffe, Louis Staudt and Robert Yarchoan at The National Institutes of Health recipients of Departmental Awards from the U.S. Department of Health and Human Services (HHS) for their groundbreaking research leading to …
We are thrilled to announce ACSR’s highly valued relationship with Proscia®. Read the full release below for more on how enterprise digital pathology thru Proscia Concentriq is helping the ACSR …
Learn more about ComboMATCH: the new clinical trial initiative to evaluate combinations of treatments that block both the drivers of tumor growth and the mechanisms of resistance. The primary goal for ComboMATCH …
The ACSR congratulates Dr. Monica Bertagnolli as she takes the helm as the 17th NIH Director! She is the first surgeon and the second woman to hold the position. Nominated …
City of Hope’s, in person and virtual, Global Oncology Symposium on Oncogenic Viruses will take place Fri, Oct 27, 8 a.m.-3:30 p.m. PDT. The symposium promises to cover a comprehensive …
Read “Tackling cancer globally requires research commitments in LMICs”, the latest Worldview Editorial in Nature written by Dr. Satish Gopal, Director of the National Cancer Institute’s Center for Global Health. …
The Biden-Harris Administration, through NCI, is committing $5.4 million in the first year of these multi-year awards to support the inaugural cohort of 11 Cancer Moonshot Scholars. The inaugural cohort …
From Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings NOT-CA-23-078 NCI encourages applications for pragmatic clinical trials to generate evidence that directly informs decision-making among patients, providers, …